Manganese-52 positron emission tomography tracer characterization and initial results in phantoms and in vivo

被引:46
|
作者
Topping, Geoffrey J. [1 ]
Schaffer, Paul [2 ]
Hoehr, Cornelia [2 ]
Ruth, Thomas J. [2 ]
Sossi, Vesna [1 ]
机构
[1] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 2B5, Canada
[2] TRIUMF, Nucl Med, Vancouver, BC V6T 2A3, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
Manganese-52; PET; MANGANESE-ENHANCED MRI; BRAIN; ACTIVATION; SIMULATION; EMITTERS; CHROMIUM; SCANNER;
D O I
10.1118/1.4793756
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: Manganese(II) is employed as a contrast agent with magnetic resonance imaging (MRI) for study of neuronal activation in rats and mice. However, at the concentrations required for MRI, Mn may induce pharmacological or toxic effects. Positron emission tomography (PET) imaging of (MnCl2)-Mn-52 at tracer doses has the potential to allow similar Mn studies as manganese-enhanced MRI while providing quantitative results and avoiding toxic effects. In this work, (MnCl2)-Mn-52 is produced and characterized as a PET tracer in phantoms and in rats. Methods: (MnCl2)-Mn-52 was produced by proton irradiation of natural Cr foil and separated by column chromatography. Images were acquired on a Siemens Focus 120 small animal PET scanner. Phantom images were acquired to assess uniformity, resolution, cascade background correction, and count rate linearity. Images of rats were also acquired after systemic and intracerebroventricular (ICV) administration of (MnCl2)-Mn-52 to investigate Mn(II) distribution in vivo. Results: Irradiation yield was 74.6 +/- 8.5 kBq/mu A min Mn-52 at end of bombardment with initial specific activity of at least 3.5 MBq/nmol. Mn-52 PET images show similar uniformity and resolution to F-18. F-18 based detector efficiency normalization is adequate for Mn-52 imaging. Subtraction of a rescaled random events distribution from sinogram data is effective for cascade correction of Mn-52 PET data. After systemic injection, Mn-52 appears in structures throughout the body of rats, including bones, liver, intestines, and the pituitary gland, but does not appear detectably throughout the brain. After ICY injection, Mn-52 remains in the brain and spinal cord. Conclusions: Mn-52 is a promising tracer for small animal PET imaging, yielding image quality comparable to F-18. Potential applications include studies similar to Mn-enhanced neuronal MRI, and in other organ systems including bones, spinal cord, and the digestive tract. (C) 2013 American Association of Physicists in Medicine. [http://dx.doi.org/10.1118/1.4793756]
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Radiosynthesis and In Vivo Evaluation of Four Positron Emission Tomography Tracer Candidates for Imaging of Melatonin Receptors
    Bdair, Hussein
    Singleton, Thomas A.
    Ross, Karen
    Jolly, Dean
    Kang, Min Su
    Aliaga, Arturo
    Tuznik, Marius
    Kaur, Tanpreet
    Yous, Said
    Soucy, Jean-Paul
    Massarweh, Gassan
    Scott, Peter J. H.
    Koeppe, Robert
    Spadoni, Gilberto
    Bedini, Annalida
    Rudko, David A.
    Gobbi, Gabriella
    Benkelfat, Chawki
    Rosa-Neto, Pedro
    Brooks, Allen F.
    Kostikov, Alexey
    ACS CHEMICAL NEUROSCIENCE, 2022, 13 (09): : 1382 - 1394
  • [2] Positron emission tomography radioligands for in vivo imaging of Aβ plaques
    Mason, N. Scott
    Mathis, Chester A.
    Klunk, William E.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 (3-4): : 89 - 95
  • [3] Anatomy, Functionality, and Neuronal Connectivity with Manganese Radiotracers for Positron Emission Tomography
    Saar, Galit
    Millo, Corina M.
    Szajek, Lawrence P.
    Bacon, Jeff
    Herscovitch, Peter
    Koretsky, Alan P.
    MOLECULAR IMAGING AND BIOLOGY, 2018, 20 (04) : 562 - 574
  • [4] Imaging and analysis of thin structures using positron emission tomography: Thin phantoms and in vivo tobacco leaves study
    Partelova, Denisa
    Hornik, Miroslav
    Lesny, Juraj
    Rajec, Pavol
    Kovac, Peter
    Hostin, Stanislav
    APPLIED RADIATION AND ISOTOPES, 2016, 115 : 87 - 96
  • [5] Positron emission tomography imaging in evaluation of MS pathology in vivo
    Hogel, Heidi
    Rissanen, Eero
    Vuorimaa, Anna
    Airas, Laura
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (11) : 1399 - 1412
  • [6] Dual-Tracer Positron-Emission Tomography for Identification of Culprit Carotid Plaques and Pathophysiology In Vivo
    Evans, Nicholas R.
    Tarkin, Jason M.
    Chowdhury, Mohammed M.
    Le Elizabeth, P., V
    Coughlin, Patrick A.
    Rudd, James H. F.
    Warburton, Elizabeth A.
    CIRCULATION-CARDIOVASCULAR IMAGING, 2020, 13 (03) : E009539
  • [7] Characterization of positron emission tomography hypoxia tracer uptake and tissue oxygenation via electrochemical modeling
    Bowen, Stephen R.
    van der Kogelb, Albert J.
    Nordsmark, Marianne
    Bentzen, Soren M.
    Jeraj, Robert
    NUCLEAR MEDICINE AND BIOLOGY, 2011, 38 (06) : 771 - 780
  • [8] Diagnostic accuracy of fused positron emission tomography/magnetic resonance mammography: initial results
    Heusner, T. A.
    Hahn, S.
    Jonkmanns, C.
    Kuemmel, S.
    Otterbach, F.
    Hamami, M. E.
    Stahl, A. R.
    Bockisch, A.
    Forsting, M.
    Antoch, G.
    BRITISH JOURNAL OF RADIOLOGY, 2011, 84 (998): : 126 - 135
  • [9] 18F-labeled radiotracers for in vivo imaging of DREADD with positron emission tomography
    Hu, Feng
    Morris, Patrick J.
    Bonaventura, Jordi
    Fan, Hong
    Mathews, William B.
    Holt, Daniel P.
    Lam, Sherry
    Boehm, Matthew
    Dannals, Robert F.
    Pomper, Martin G.
    Michaelides, Michael
    Horti, Andrew G.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 213
  • [10] Positron Emission Mammography: Initial Clinical Results
    Edward A. Levine
    Rita I. Freimanis
    Nancy D. Perrier
    Kathryn Morton
    Nadia M. Lesko
    Simon Bergman
    Kim R. Geisinger
    Rodney C. Williams
    Connie Sharpe
    Valera Zavarzin
    Irving N. Weinberg
    Pavel Y. Stepanov
    David Beylin
    Kathryn Lauckner
    Mohan Doss
    Judy Lovelace
    Lee P. Adler
    Annals of Surgical Oncology, 2003, 10 : 86 - 91